Table II.
Number of 20-AARs retained in germline/somatic mutations | |||||||
---|---|---|---|---|---|---|---|
Cancer type | 0/0 | 0/1 or 1/0 | 0/2 or 2/0 | 0/3 or 3/0 | 1/2 or 2/1 | 1/3 or 3/1 | 2/3 or 3/2 |
TC | 13 | 0 | 1 | 2 | 0 | 0 | 0 |
TC, thyroid cancer; 20-AARs, 20-amino acid repeats.
Number of 20-AARs retained in germline/somatic mutations | |||||||
---|---|---|---|---|---|---|---|
Cancer type | 0/0 | 0/1 or 1/0 | 0/2 or 2/0 | 0/3 or 3/0 | 1/2 or 2/1 | 1/3 or 3/1 | 2/3 or 3/2 |
TC | 13 | 0 | 1 | 2 | 0 | 0 | 0 |
TC, thyroid cancer; 20-AARs, 20-amino acid repeats.